跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMBIVENT - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
AMBIVENT
Approved
STANDARD
AMBIVENT
MGRM Medicare Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ab9441319c609342
Company
MGRM Medicare Ltd.
Type
Standard
Approval Details
Approval Id
ab9441319c609342
Drug Approval Philippines Name
AMBIVENT
Product Name
AMBIVENT
Registration Number
DRP-4672-02
Brand Name
AMBIVENT
Generic Name
Salbutamol (as sulfate ) + Ipratropium bromide
Dosage Form
Solution For Nebulization
Dosage Strength
2.5mg/ 500mcg / 2.5 mL
Manufacturer
MGRM Medicare Ltd.
Importer
I.E. Medica, Inc.
Distributor
Madecs Trading Corp.
Issuance Date
28 November 2023
Expiry Date
02 February 2028
Pharmacologic Category
Bronchodilator
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ab9441319c609342
Type
Standard
Back to Philippines FDA Approvals